The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level

Atherosclerosis. 1995 Oct;117(2):305-8. doi: 10.1016/0021-9150(95)05566-f.

Abstract

The degree of serum cholesterol lowering by up to almost maximal inhibition of cholesterol absorption was tested during neomycin and neomycin + sitostanol treatment in six hypercholesterolemic men. Neomycin decreased cholesterol absorption efficiency by 49% and the combination by 79%, and serum cholesterol level by 27% and 36%, respectively. The correlation between the absorption percentage and low density lipoprotein (LDL) cholesterol was significant (r = 0.510), and the regression equation (y = 0.04x + 2.59) suggested that the mean LDL cholesterol content would be about 2.5 mmol/l at zero cholesterol absorption. In conclusion, in hypercholesterolemic subjects, the lowering of LDL cholesterol appears to be limited to a low normal range only by almost totally inhibiting cholesterol absorption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption
  • Anticholesteremic Agents / pharmacology*
  • Cholesterol / metabolism*
  • Cholesterol, LDL / blood*
  • Humans
  • Hypercholesterolemia / metabolism*
  • Male
  • Middle Aged
  • Neomycin / pharmacology*
  • Sitosterols / pharmacology*

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Sitosterols
  • Cholesterol
  • stigmastanol
  • Neomycin